Jane Street’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-173,511
| Closed | -$2.27M | – | 11538 |
|
|
2025
Q4 | $2.27M | Sell |
173,511
-45,813
| -21% | -$547K | ﹤0.01% | 4569 |
|
|
2025
Q3 | $1.6M | Buy |
219,324
+145,080
| +195% | +$982K | ﹤0.01% | 5354 |
|
|
2025
Q2 | $398K | Sell |
74,244
-34,654
| -32% | -$168K | ﹤0.01% | 7353 |
|
|
2025
Q1 | $582K | Buy |
108,898
+82,805
| +317% | +$579K | ﹤0.01% | 6584 |
|
|
2024
Q4 | $233K | Sell |
26,093
-10,643
| -29% | -$113K | ﹤0.01% | 8151 |
|
|
2024
Q3 | $404K | Sell |
36,736
-90,644
| -71% | -$1.01M | ﹤0.01% | 7546 |
|
|
2024
Q2 | $1.16M | Buy |
127,380
+93,550
| +277% | +$913K | ﹤0.01% | 5497 |
|
|
2024
Q1 | $476K | Sell |
33,830
-6,247
| -16% | -$77.8K | ﹤0.01% | 6765 |
|
|
2023
Q4 | $308K | Buy |
+40,077
| New | +$222K | ﹤0.01% | 7564 |
|
|
2023
Q3 | – | Sell |
-10,751
| Closed | -$89.6K | – | 8602 |
|
|
2023
Q2 | $89.6K | Sell |
10,751
-91,084
| -89% | -$1.05M | ﹤0.01% | 8048 |
|
|
2023
Q1 | $1.35M | Buy |
101,835
+90,840
| +826% | +$1.23M | ﹤0.01% | 4466 |
|
|
2022
Q4 | $164K | Sell |
10,995
-10,503
| -49% | -$108K | ﹤0.01% | 7812 |
|
|
2022
Q3 | $194K | Buy |
+21,498
| New | +$144K | ﹤0.01% | 8205 |
|
|
2021
Q3 | – | Sell |
-4,583
| Closed | -$58K | – | 9892 |
|
|
2021
Q2 | $58K | Buy |
+4,583
| New | +$59.5K | ﹤0.01% | 9467 |
|
|
2021
Q1 | – | Sell |
-10,167
| Closed | -$131K | – | 9064 |
|
|
2020
Q4 | $131K | Buy |
+10,167
| New | +$181K | ﹤0.01% | 7121 |
|
|
2020
Q3 | – | Sell |
-2,277
| Closed | -$88K | – | 7120 |
|
|
2020
Q2 | $88K | Buy |
+2,277
| New | +$81.1K | ﹤0.01% | 6756 |
|
|
2020
Q1 | – | Sell |
-2,456
| Closed | -$87K | – | 5272 |
|
|
2019
Q4 | $87K | Buy |
+2,456
| New | +$77.4K | ﹤0.01% | 4864 |
|
|
2018
Q3 | – | Sell |
-387
| Closed | -$22K | – | 5059 |
|
|
2018
Q2 | $22K | Buy |
+387
| New | +$35.7K | ﹤0.01% | 4861 |
|
|
2017
Q4 | – | Sell |
-195
| Closed | -$25K | – | 4540 |
|
|
2017
Q3 | $25K | Buy |
+195
| New | +$16.3K | ﹤0.01% | 4349 |
|
Jane Street's ATXS Position: Q1 2026 in Review
Jane Street sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 173,511 shares — an estimated $2.27M sold.
Jane Street first reported a position in ATXS in Q3 2017 and held it in 19 quarters. The position peaked at $2.27M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Jane Street reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 173,511 Astria Therapeutics shares in Q1 2026, an estimated $2.27M.
- Jane Street first reported a position in Astria Therapeutics in Q3 2017 and held it in 19 quarters.
- Jane Street's Astria Therapeutics position peaked at $2.27M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.